Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two weeks of March 2024.
See previous edition Psychedelics Headlines: Substitution Survey, Frank Herbert’s Magic Mushrooms, Celestial Plans And News Review
Research
Psychedelic Therapy as a Form of Life (original read,)
Scoping Review: The Role of Psychedelics in the Management of Chronic Pain (original read.)
Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study (original read.)
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression (original read.)
Exploring the discourses around microdosing psychedelics within the r/microdosing online community (original read.)
UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study (original read.)
Cultural Divergence in Psychedelic Use among Medical Students: An ESPAD-Adapted Survey among Poles and Iraqis (original read.)
Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties (original read.)
Safety pharmacology of acute psilocybin administration in healthy participants (original read.)
First Proof that Psilacetin is a Prodrug of Psilocin, coverage by Psychedelic Science Review.
Come and learn all about the latest trends in the cannabis sector at our upcoming Benzinga Cannabis Capital Conference!
Tune In, Get Smart
“The Psychedelic Evangelist,” on belated, respected field researcher Dr. Roland …